Insmed (INSM) Tops Q1 EPS by 17c ; Offers Guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $102.15 +3.59%
Revenue Growth %: +264.2%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +264.2%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.06), $0.17 better than the analyst estimate of ($1.23). Revenue for the quarter came in at $75.5 million versus the consensus estimate of $78.51 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $354.7 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Nike names former Pfizer CFO David Denton as new finance chief
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
